Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Apacef
2. Apatef
3. Cefotan
4. Cefotetan
5. Cefotetan Disodium Salt
6. Ceftotan
7. Disodium Salt, Cefotetan
8. Disodium, Cefotetan
9. Ici 156834
10. Ici-156834
11. Ici156834
12. Salt, Cefotetan Disodium
13. Ym 09330
14. Ym-09330
15. Ym09330
1. Cefotetan Sodium
2. Cefotetan Disodium Salt
3. Cefotan
4. 74356-00-6
5. Yamatetan
6. Apatef
7. Cepan
8. Ym-09330
9. Ym 09330
10. 0gxp746vxb
11. Chebi:34617
12. 74356-00-6 (sodium)
13. (6r,7s)-7-(4-(carbamoylcarboxymethylene)-1,3-dithietane-2-carboxamido)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, Disodium Salt
14. Ceftenon
15. Darvilen
16. Cefotetan Sodium (jan)
17. Ici 156834 Disodium
18. Cefotetan Sodium [jan]
19. Cefotetan Disodium [usan]
20. Sodium (6r,7s)-7-[[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
21. Cefotan In Plastic Container
22. Einecs 277-834-9
23. Unii-0gxp746vxb
24. Cefotetandisodium
25. Cefotetan Disodium [usan:usp]
26. Cefotan (tn)
27. Cefotetan And Dextrose In Duplex Container
28. Cefotetan Disodium (usp)
29. Schembl40794
30. (6r,7s)-4-((2-carboxy-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-7-yl)carbamoyl)-1,3-dithietane-delta(sup 2,alpha)-malonamic Acid, Disodium Salt
31. Chembl1201098
32. Cefotetan Disodium [vandf]
33. Cefotetan Disodium [mart.]
34. Cefotetan Disodium [who-dd]
35. Disodium;(6r,7s)-7-[[4-(2-amino-1-carboxylato-2-oxoethylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
36. Akos025311215
37. Cefotetan Disodium [orange Book]
38. Cefotetan Disodium [usp Impurity]
39. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, Disodium Salt, (6r-(6alpha,7alpha))-
40. Cefotetan Disodium [usp Monograph]
41. C-2473
42. D02228
43. Cefotetan Disodium, Antibiotic For Culture Media Use Only
44. (6r,7s)-4-((2-carboxy-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-7-yl)carbamoyl)-1,3-dithietane-.delta.(sup 2,.alpha.)-malonamic Acid, Disodium Salt
45. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, Disodium Salt, (6r-(6.alpha.,7.alpha.))-
46. Disodium (6r,7s)-7-({[4-(2-amino-1-carboxylato-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7-methoxy-3-{[(1-methyl-1h-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
47. Disodium 7beta-({[4-(2-amino-1-carboxylato-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7alpha-methoxy-3-{[(1-methyl-1h-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylate
48. Disodium(7r)-7-[[4-(carbamoyl-carboxylato-methylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
49. Sodium (6r,7s)-7-(4-(2-amino-1-carboxylato-2-oxoethylidene)-1,3-dithietane-2-carboxamido)-7-methoxy-3-((1-methyl-1h-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
| Molecular Weight | 619.6 g/mol |
|---|---|
| Molecular Formula | C17H15N7Na2O8S4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 15 |
| Rotatable Bond Count | 7 |
| Exact Mass | 618.96603372 g/mol |
| Monoisotopic Mass | 618.96603372 g/mol |
| Topological Polar Surface Area | 327 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 1080 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
| 1 of 2 | |
|---|---|
| Drug Name | Cefotetan and dextrose in duplex container |
| Active Ingredient | Cefotetan disodium |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 2gm base/vial; eq 1gm base/vial |
| Market Status | Prescription |
| Company | B Braun |
| 2 of 2 | |
|---|---|
| Drug Name | Cefotetan and dextrose in duplex container |
| Active Ingredient | Cefotetan disodium |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 2gm base/vial; eq 1gm base/vial |
| Market Status | Prescription |
| Company | B Braun |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - INJECTABLE;INJECTION - EQ 1GM BASE/V...DOSAGE - INJECTABLE;INJECTION - EQ 1GM BASE/VIAL
USFDA APPLICATION NUMBER - 65430
DOSAGE - INJECTABLE;INJECTION - EQ 2GM BASE/V...DOSAGE - INJECTABLE;INJECTION - EQ 2GM BASE/VIAL
USFDA APPLICATION NUMBER - 65430
Related Excipient Companies
Excipients by Applications
Parenteral
Fillers, Diluents & Binders
Market Place
APIs
Reply
30 Oct 2018
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
Comment (0)
